Fed. Circ. OKs Eagle's Generic Vasostrict In Loss For Endo
The Federal Circuit on Thursday upheld a Delaware federal judge's ruling that patents owned by an Endo International unit covering the low-blood-pressure drug Vasostrict are not infringed by a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article